Native joint-resident mesenchymal stem cells for cartilage repair in osteoarthritis

Dennis McGonagle,Thomas G. Baboolal,Elena Jones
DOI: https://doi.org/10.1038/nrrheum.2017.182
IF: 32.286
2017-11-09
Nature Reviews Rheumatology
Abstract:Key PointsAlthough historically considered to be very rare cells, native mesenchymal stem cells (MSCs) are actually relatively abundant in vivoJoint-resident MSCs occupy several bone and joint cavity niches including synovium, adipose tissue and synovial fluidAdvanced osteoarthritis (OA) is associated with a numerical increase, but functional decline, in MSCs in regions of MRI-determined bone oedema, suggesting direct involvement of MSCs in OA pathology in vivoThe expression of CD271 (also known as low-affinity nerve growth factor receptor) on native bone marrow-resident MSCs might be important in pathological bone changes following anti-nerve growth factor therapyIn experimental models, there is strong evidence for the involvement of synovium-derived MSCs in cartilage repair following joint injuryEmerging features of joint-resident MSCs suggests the potential for their use in the development of single-stage therapy to treat large cartilage defects in patients with OA
rheumatology
What problem does this paper attempt to address?